Kozak Igor, Luttrull Jeffrey K
King Khaled Eye Specialist Hospital, Vitreoretinal Division, Riyadh, Saudi Arabia.
Private Retina Practice, 3160 Telegraph Road, Suite 230, Ventura, CA, USA.
Saudi J Ophthalmol. 2015 Apr-Jun;29(2):137-46. doi: 10.1016/j.sjopt.2014.09.001. Epub 2014 Sep 28.
Medicinal lasers are a standard source of light to produce retinal tissue photocoagulation to treat retinovascular disease. The Diabetic Retinopathy Study and the Early Treatment Diabetic Retinopathy Study were large randomized clinical trials that have shown beneficial effect of retinal laser photocoagulation in diabetic retinopathy and have dictated the standard of care for decades. However, current treatment protocols undergo modifications. Types of lasers used in treatment of retinal diseases include argon, diode, dye and multicolor lasers, micropulse lasers and lasers for photodynamic therapy. Delivery systems include contact lens slit-lamp laser delivery, indirect ophthalmocope based laser photocoagulation and camera based navigated retinal photocoagulation with retinal eye-tracking. Selective targeted photocoagulation could be a future alternative to panretinal photocoagulation.
医用激光是用于产生视网膜组织光凝以治疗视网膜血管疾病的标准光源。糖尿病视网膜病变研究和早期糖尿病视网膜病变研究是大型随机临床试验，这些试验已表明视网膜激光光凝在糖尿病视网膜病变中的有益效果，并在数十年间一直主导着治疗标准。然而，当前的治疗方案正在进行修改。用于治疗视网膜疾病的激光类型包括氩激光、二极管激光、染料激光和多色激光、微脉冲激光以及光动力疗法用激光。输送系统包括接触镜裂隙灯激光输送、间接检眼镜激光光凝以及基于摄像头的带有视网膜眼动追踪的导航视网膜光凝。选择性靶向光凝可能是全视网膜光凝未来的替代方法。
